These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9771958)

  • 1. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
    Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
    Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    Pharm Res; 2001 Jun; 18(6):838-45. PubMed ID: 11474789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
    Cooper M; Sologuren A; Valiente R; Smith J
    Arzneimittelforschung; 2002; 52(9):689-94. PubMed ID: 12404884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacological effect of lerisetron, a new 5-HT3 antagonist, in rats.
    Jauregizar N; Calvo R; Suarez E; Quintana A; Raczka E; Lukas JC
    J Pharm Sci; 2002 Jan; 91(1):41-52. PubMed ID: 11782896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of itraconazole and fluconazole in patients with cancer.
    Arredondo G; Calvo R; Marcos F; Martínez-Jordá R; Suarez E
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related changes in pharmacokinetics and pharmacodynamics of lerisetron in the rat: a population pharmacokinetic model.
    Jauregizar N; Quintana A; Suarez E; Raczka E; de la Fuente L; Calvo R
    Gerontology; 2003; 49(4):205-14. PubMed ID: 12792155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT(3)R binding of lerisetron: an interdisciplinary approach to drug-Receptor interactions.
    Parihar HS; Suryanarayanan A; Ma C; Joshi P; Venkataraman P; Schulte MK; Kirschbaum KS
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2133-6. PubMed ID: 11514154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic effects of Lerisetron in radiation-induced emesis in the dog.
    Gomez-de-Segura IA; Grande AG; De Miguel E
    Acta Oncol; 1998; 37(7-8):759-63. PubMed ID: 10050999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria.
    Wanwimolruk S; Denton JR
    J Pharm Pharmacol; 1992 Oct; 44(10):806-11. PubMed ID: 1360505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
    Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic-pharmacodynamic modeling of the hydroxy lerisetron metabolite L6-OH in rats: an integrated parent-metabolite model.
    Ortega F; Quintana A; Suárez E; Lukas JC; Jauregizar N; de la Fuente L; Lucero ML; Gonzalo A; Orjales A; Calvo R
    Pharm Res; 2005 Nov; 22(11):1769-82. PubMed ID: 16158214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX; Cao LS; Samii K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional group interactions of a 5-HT3R antagonist.
    Venkataraman P; Joshi P; Venkatachalan SP; Muthalagi M; Parihar HS; Kirschbaum KS; Schulte MK
    BMC Biochem; 2002 Jun; 3():16. PubMed ID: 12079499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of alfentanil to human alpha 1-acid glycoprotein, albumin and serum.
    Belpaire FM; Bogaert MG
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):96-102. PubMed ID: 2071261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lerisetron. F 0930, F 0930RS.
    Drugs R D; 1999 Oct; 2(4):245-6. PubMed ID: 10659400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.